Eiger BioPharmaceuticals, Inc. EIGRQ
8.50
0.00
0.00%
as of 1 Oct
- Market cap
- $2.6M
- P/E
- 0.0×
Follow EIGRQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(146.28%) | (161.95%) | (225.93%) | (367.00%) | |
| (76.75%) | (81.11%) | (86.91%) | (94.31%) | ||
ROIC |
(14,894.98%) | (2,469.33%) | 0.00% | (3,674.55%) | |
Return on Tangible Assets |
(131.47%) | (175.56%) | (223.45%) | 505.89% | |
Average Days of Receivables |
95.13 | 87.59 | 32.88 | 38.92 | |
Free Cash Flow per Share |
(60.62) | (60.61) | (56.44) | (50.67) | |
Free Cash Flow |
(89.11) | (89.41) | (83.30) | (74.78) | |
Capital Expenditures |
(0.56) | (0.56) | (0.46) | (0.23) | |
Piotroski F-Score |
3.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(58.67%) | (81.08%) | (105.19%) | (143.08%) | |
Accounts Receivable Turnover |
4.83 | 6.51 | 7.76 | 9.19 | |
Accounts Payable Turnover |
0.18 | 0.19 | 0.03 | 0.00 | |
Inventory Turnover |
0.51 | 0.70 | 0.14 | 0.01 | |
Average Days of Payables |
2,345.89 | 1,304.40 | 6,616.31 | 32,165.63 | |
Days of Inventory on Hand |
1,056.03 | 289.57 | 1,504.94 | 23,664.17 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
498.76% | 496.53% | 472.10% | 395.18% | |
Selling, General and Administrative Expense of Revenue |
213.06% | 195.81% | 196.39% | 159.79% | |
Share Based Compensation of Revenue |
59.03% | 47.47% | 42.04% | 31.75% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 0.93 | 0.96 | 0.99 | |
Depreciation/Fixed assets |
0.34 | (0.50) | (1.14) | (1.33) | |
Capex/Depreciation |
(2.05) | 1.51 | 0.59 | 0.28 | |
Revenue per Share |
10.16 | 10.49 | 9.94 | 10.69 | |
Operating CF per Share |
(60.24) | (60.23) | (56.13) | (50.51) | |
Capex per Share |
(0.38) | (0.38) | (0.31) | (0.16) | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.01 | |
Net Profit Margin |
(649.19%) | (618.36%) | (590.80%) | (475.26%) |
Columns are period end dates